Picture of Galera Therapeutics logo

GRTX Galera Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSuper Stock

Brief: Galera Therapeutics Reports Q3 Loss Per Share $0.69

Nov 10 (Reuters) - Galera Therapeutics Inc  GRTX.O :
    * GALERA THERAPEUTICS REPORTS THIRD QUARTER 2020 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATES
    * Q3 LOSS PER SHARE $0.69
    * Q3 EARNINGS PER SHARE ESTIMATE $-0.77 -- REFINITIV IBES
DATA
    * GALERA THERAPEUTICS - EXPECTS EXISTING CASH RESOURCES WITH
EXPECTED PAYMENTS WILL FUND OPERATING EXPENSES AND CAPITAL
EXPENDITURE INTO H2 OF 2022

Source text for Eikon:  ID:nGNX2rKNDp 
Further company coverage:  GRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Galera Therapeutics

See all news